fbpx

Day

September 8, 2015
Financing will advance Sanifit's lead drug candidate through phase IIb as a treatment for cardiovascular diseases linked to calcification and throughphase II/III for calciphylaxis.Palma de Mallorca, Spain, September 8, 2015 - Laboratoris Sanifit S.L., a clinical-stagebiopharmaceutical company, today announces that it has raised ?36.6M ($41.3M) in a SeriesC financing round. The company is focused on the...

News

Seven research institutions receive DKK 20 million for coronavirus research
1. April 2020
How we handle changes to research projects in light of the coronavirus pandemic
31. March 2020
Lundbeck Foundation gives its first coronavirus grant to trial with a known drug
26. March 2020

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge